AREC — Arecor Therapeutics Share News
0.000.00%
Last trade - 00:00
- £41.81m
- £33.74m
- £2.40m
REG - Arecor Therapeutics - Publication of Full Year Financial Results delayed
AnnouncementREG - Arecor Therapeutics - BOARD CHANGE
AnnouncementREG - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementRCS - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementREG - Arecor Therapeutics - Arecor announces launch of Ogluo® in Netherlands
AnnouncementREG - Arecor Therapeutics - Year End Trading Update
AnnouncementREG - Arecor Therapeutics - Arecor announces update on INBRX-101
AnnouncementREG - Arecor Therapeutics - Arecor granted key European patent
AnnouncementREG - Arecor Therapeutics - Expansion of specialty hospital collaboration
AnnouncementREG - Arecor Therapeutics - Appointment of SVP for Tetris Pharma Ltd
AnnouncementREG - Arecor Therapeutics - Agreement with global medical products company
AnnouncementREG - Arecor Therapeutics - Arecor Continues Collaboration with Lilly
AnnouncementREG - Arecor Therapeutics - Product with Arestat technology launched in Europe
AnnouncementREG - AIM - AIM Notice - 07/11/2023
AnnouncementREG - Arecor Therapeutics - Inhibrx milestone triggers payment to Arecor
AnnouncementREG - Arecor Therapeutics - Exercise of rollover options & Total Voting Rights
AnnouncementREG - Arecor Therapeutics - Progress of Phase I clinical study of AT278
AnnouncementRCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - Interim Results for six months ended 30 June 2023
Announcement